The company utilizes multi-modal sensors and advanced AI to create predictive biomarkers for pre-symptomatic disease detection and personalized therapy. Their platform aims to revolutionize the way diseases are detected and treated by providing accurate and timely diagnoses, reducing healthcare costs, and improving patient outcomes. Cardiosense is committed to improving global health by making their technology accessible to healthcare providers worldwide. For more information, contact them at [email protected].